Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-28 @ 8:34 AM
Study NCT ID:
NCT00796835
Status:
COMPLETED
Last Update Posted:
2011-05-24
First Post:
2008-11-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-20
First Submit QC Date:
None
Study First Post Date:
2008-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-20
Last Update Post Date:
2011-05-24
Last Update Post Date Type:
ESTIMATED